Biovest International, Inc. is a publicly-traded (OTCQB: BVTI), emerging leader in the field of active personalized immunotherapy targeting life-threatening cancers of the blood system, and markets state-of-the-art hollow fiber bio-production instruments, as well as provides custom cell culture services, including contract manufacturing...More>>
|There are currently no events scheduled.|
Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever Biovest International Inc. posts new information to the site. Just enter your e-mail address and click Submit.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.